GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Proteomics International Laboratories PIQ.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.10

-2.04%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Proteomics International Laboratories — daily ASX:PIQ

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Proteomics International Laboratories on TradingView ↗
Market value
A$15.9m
Last close × shares
Volume
111.2k
Shares, 9 Nov 2026

About Proteomics International Laboratories

Its shares trade on ASX under the ticker PIQ.AX. It has been listed since 16 April 2015. In the fiscal year to 30 June 2026, it reported revenue of A$278,015 and a net loss of A$8.6m. At that date it held total assets of A$8.9m and shareholders' equity of A$5.8m.

Proteomics International Laboratories Ltd. is a medical technology company which operates at the forefront of predictive diagnostics and bio-analytical services. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2015-04-16. The firm is engaged in predictive diagnostics and bio-analytical services. The firm specializes in proteomics, the study of the structure and function of proteins. The firm focuses on developing and commercializing diagnostic tests for chronic diseases. The firm operates in three business units unified by a technology platform: PromarkerD, Diagnostics and Analytical Services. The PromarkerD test system is a blood test that assess the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes. Diagnostics includes Promarker platform, used to discover, verify, and analytically validate the panel of protein biomarkers for diabetic kidney disease. Its Analytical Services includes a proteomics-based technology platform, used to test, and validate the protein composition of varied range of products.

Figures and description from our data supplier, not checked against the company's own report.

More about Proteomics International Laboratories →

Latest on Proteomics International Laboratories

Our reporting

We have not reported on Proteomics International Laboratories yet.

Next results

25 Feb 2027

Due on 25 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Proteomics International Laboratories's ticker?

Proteomics International Laboratories trades as PIQ.AX on ASX, under ISIN AU000000PIQ0.

What was Proteomics International Laboratories's last closing price?

0.10 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Proteomics International Laboratories next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.